Sickle Cell Disease Treatment Market Research Report 2022-2027: Industry Growth Rate (16.0%), Statistics, Share, Size, and Forecast

According to the latest report by IMARC Group, titled "Sickle Cell Disease Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027," the global sickle cell disease treatment market size reached US$ 2.6 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 6.4 Billion by 2027, exhibiting a growth rate (CAGR) of 16.0% during 2022-2027. Sickle cell disease refers to a genetic red blood cell (RBC) disorder. It severely affects hemoglobin, a protein that carries oxygen throughout the body and leads to numerous complications, including acute chest syndrome, anemia, Vaso-occlusive crisis (VOC), etc. There are various types of treatment available for controlling sickle cell disease, such as blood and bone marrow transplant, blood transfusions, pharmacotherapy, etc. They help reduce the symptoms and prolong the life of patients. Consequently, sickle cell disease treatments are extensively utilized in hospitals, specialty clinics, and other healthcare establishments.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/sickle-cell-disease-treatment-market/requestsample

Global Sickle Cell Disease Treatment Market Trends:

The increasing research on gene therapy is among the key factors driving the sickle cell disease treatment market. Furthermore, the elevating focus among the health regulatory authorities of several countries towards fast-track approval of new treatment methods is acting as another significant growth-inducing factor. Besides this, the rising prevalence of sickle cell anemia among both adults and children and the growing usage of the blood transfusion segment across the globe are also positively influencing the market growth. Apart from this, the inflating investments undertaken by the government bodies in the developing countries for improving the healthcare infrastructure and the expanding awareness among individuals about the available medical therapies are anticipated to augment the sickle cell disease treatment market over the forecasted period.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/sickle-cell-disease-treatment-market

Global Sickle Cell Disease Treatment Market 2022-2027 Analysis and Segmentation:

Competitive Landscape with Key Players:

• AstraZeneca Plc
• Baxter International Inc.
• bluebird bio Inc.
• Bristol-Myers Squibb Company
• CRISPR Therapeutics
• Emmaus Medical Inc
• Global Blood Therapeutics Inc.
• GlycoMimetics Inc
• Novartis AG
• Pfizer Inc
• Sangamo Therapeutics

Breakup by Treatment Type:

• Blood Transfusion
• Pharmacotherapy
• Bone Marrow Transplant

Breakup by End User:

• Hospitals
• Diagnostic centers
• Others

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Reports of IMARC Group:

• https://icrowdnewswire.com/2022/05/10/devops-market-analysis-report-2022-2027-industry-current-trends-growth-future-demand-top-companies-share-size-and-forecast/
• https://icrowdnewswire.com/2022/05/21/india-metal-casting-market-analysis-2022-growth-overview-upcoming-trends-and-forecast-by-2027/
• https://icrowdnewswire.com/2022/05/21/deep-learning-market-research-report-2022-2027-industry-size-growth-opportunity-and-forecast/
• https://icrowdnewswire.com/2022/05/21/metal-powder-market-overview-2022-top-manufacturers-share-size-growth-analysis-report-by-2027/
• https://icrowdnewswire.com/2022/06/14/ceramide-market-to-reach-us-503-3-million-by-2027-cagr-of-5-70/

Contact Us:

IMARC Group
30 N Gould St, Ste R
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.